The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
Open accessAbstract
Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpose. This article examines the evidence for performance of diabetes risk scores in adults by 1) systematically reviewing the literature on available scores and 2) their validation in external populations; and 3) exploring methodological issues surrounding the development, validation, and comparison of risk scores. Risk scores show overall good discriminatory ability in populations for whom they were developed. However, discriminatory performance is more heterogeneous and generally weaker in external populations, which suggests that risk scores may need to be validated within the population in which they are intended to be used. Whether risk scores enable accurate estimation of absolute risk remains unknown; thus, care is needed when using scores to communicate absolute diabetes risk to individuals. Several risk scores predict diabetes risk based on routine noninvasive measures or on data from questionnaires. Biochemical measures, in particular fasting plasma glucose, can improve prediction of such models. On the other hand, usefulness of genetic profiling currently appears limited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, risk scores for incident diabetes based on a combination of non-invasive or blood-based risk factors are under development to identify individuals at high risk of developing diabetes.6”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
The American Journal of Managed Care
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc · Cited by 3,254
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Flagged first, then by citations
Research works printed but not linked: 7
- 2009, OBES METAB, 5, 13
- Pearson, 2003, The American journal of managed care, 9, 57
- 2007, ERNAHRUNGSUMSCHAU, 54, 122
- Tsukahara, 2005, The Journal of the Association of Physicians of India, 53, 759
- von Eckardstein, 2000, Journal of Clinical Endocrinology & Metabolism, 85, 3101, 10.1210/jc.85.9.3101 · DOI
- Alssema, 2008, Nederlands tijdschrift voor geneeskunde, 152, 2418
- 2007, ERNAHRUNGS UMSCH, 54, 698
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., Fernandes, J. D. D. R., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D. A., Shaw, J. E., & Makaroff, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 7,121
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Navarro‐González, D., Sánchez‐Íñigo, L., Delgado, J. P., Fernández‐Montero, A., & Martínez, J. A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.01.022 · Cited by 403
Hu, C., & Jia, W. (2017) · Diabetes · doi:10.2337/dbi17-0013 · Cited by 386
Abbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321
The emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307
Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Langenberg, C., Sharp, S. J., Franks, P. W., Scott, R. A., Deloukas, P., Forouhi, N. G., Froguel, P., Groop, L., Hansen, T. F., Palla, L., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001647 · Cited by 237
Self-citationStefan, N., & Schulze, M. B. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00086-4 · Cited by 215
Self-citationCollins, G. S., Omar, O., Shanyinde, M., & Yu, L.-M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.06.020 · Cited by 192
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
Ortiz‐Martínez, M., González‐González, M., Martagón, A. J., Hlavinka, V., Willson, R. C., & Rito‐Palomares, M. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01453-4 · Cited by 241
Depression and type 2 diabetes: a causal association?
Tabák, Á. G., Akbaraly, T. N., Batty, G. D., & Mika Kivimaki, B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70139-6 · Cited by 210
Genetic risk prediction in complex disease
Jostins, L., & Barrett, J. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr378 · Cited by 185
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
ller, G. M. A. U. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s32923 · Cited by 178
Kengne, A. P., Beulens, J. W. J., Peelen, L. M., Moons, K. G. M., van der Schouw, Y. T., Schulze, M. B., Spijkerman, A. M. W., Griffin, S. J., Grobbee, D. E., Palla, L., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70103-7 · Cited by 173
Self-citationCommunicating Genetic Risk Information for Common Disorders in the Era of Genomic Medicine
Lautenbach, D. M., Christensen, K. D., Sparks, J. A., & Green, R. C. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-092010-110722 · Cited by 160
Personality and risk of diabetes in adults: Pooled analysis of 5 cohort studies.
Jokela, M. M., Elovainio, M. J., Nyberg, S. T., Tabák, Á. G., Hintsa, T., Batty, G. D., & Mika Kivimaki, B. (2013) · Health Psychology · doi:10.1037/hea0000003 · Cited by 154
Diabetes Mellitus: Screening and Diagnosis.
Pippitt, K. A., Li, M., & Gurgle, H. E. (2016) · PubMed · Cited by 153
Management of NCD in Low- and Middle-Income Countries
Checkley, W., Ghannem, H., Irazola, V. E., Kimaiyo, S. N., Levitt, N. S., Miranda, J. J., Niessen, L. W., Prabhakaran, D., Rabadan‐Diehl, C., Ramírez‐Zea, M., et al. (2014) · Global Heart · doi:10.1016/j.gheart.2014.11.003 · Cited by 151
Costa, B., Barrio, F., Cabré, J.-J., Piñol, J. L., Cos, X., Solé, C., Bolíbar, B., Basora, J., Castell, C., Solà-Morales, O., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2492-6 · Cited by 143
Robinson, C. A., Agarwal, G., & Nerenberg, K. A. (2011) · Chronic diseases and injuries in Canada · doi:10.24095/hpcdp.32.1.04 · Cited by 137
Han, L., Luo, S., Yu, J., Pan, L., & Chen, S. (2014) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2014.2325615 · Cited by 135
Chamroonkiadtikun, P., Ananchaisarp, T., & Wanichanon, W. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.08.004 · Cited by 137
Seto, H., Oyama, A., Kitora, S., Toki, H., Yamamoto, R., Kotoku, J., Haga, A., Shinzawa, M., Yamakawa, M., Fukui, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20149-z · Cited by 152
Willis, A., Rivers, P. H., Gray, L. J., Davies, M. J., & Khunti, K. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091157 · Cited by 125
Metabolomics in diabetes, a review
Pallares-Méndez, R., Aguilar-Salinas, C. A., Cruz‐Bautista, I., & del Bosque‐Plata, L. (2016) · Annals of Medicine · doi:10.3109/07853890.2015.1137630 · Cited by 120
The Play of Genes and Non-genetic Factors on Type 2 Diabetes
Mambiya, M., Shang, M., Wang, Y., Li, Q., Liu, S., Yang, L., Zhang, Q., Zhang, K., Liu, M., Nie, F., et al. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00349 · Cited by 107
Marques-Vidal, P. M., Schmid, R., Bochud, M., Bastardot, F., von Känel, R., Paccaud, F. M., Glaus, J., Preisig, M., Waeber, G., & Vollenweider, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051768 · Cited by 95
Brown, N., Critchley, J., Bogowicz, P., Mayige, M. T., & Unwin, N. C. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.005 · Cited by 93
Edwards, C., & Cusi, K. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.007 · Cited by 94
Abbasi, A., Corpeleijn, E., Meijer, E., Postmus, D., Gansevoort, R. T., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2545-x · Cited by 86
Wang, X., Strizich, G., Hu, Y., Wang, T., Kaplan, R. C., & Qi, Q. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12323 · Cited by 84
Olivera, A. R., Roesler, V., Iochpe, C., Schmidt, M. I., Vigo, Á., Barreto, S. M., & Duncan, B. B. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0309010217 · Cited by 79
TheACE2G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke
Wu, Y., Li, J., Wang, C., Zhang, L., & Qiao, H. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22033 · Cited by 77
Comparison of screening scores for diabetes and prediabetes
Poltavskiy, E. A., Kim, D. J., & Bang, H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.022 · Cited by 71
The potential of novel biomarkers to improve risk prediction of type 2 diabetes
Herder, C., Kowall, B., Tabák, Á. G., & Rathmann, W. (2013) · Diabetologia · doi:10.1007/s00125-013-3061-3 · Cited by 70
Costa, B., Barrio, F., Piñol, J. L., Cabré, J.-J., Mundet, X., Sagarra-Alamo, R., Salas‐Salvadó, J., & Solà-Morales, O. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-45 · Cited by 71
Bao, W., Hu, F. B., Rong, S., Rong, Y., Bowers, K. A., Schisterman, E. F., Liu, L., & Zhang, C. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt123 · Cited by 65
Abbasi, A., Sahlqvist, A., Lotta, L. A., Brosnan, J. M., Vollenweider, P., Giabbanelli, P. J., Nunez, D. J., Waterworth, D. M., Scott, R. A., Langenberg, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163721 · Cited by 65
Gómez-Arbeláez, D. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i17.1337 · Cited by 64
The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity
Lamri, A., Pigeyre, M., Garver, W. S., & Meyre, D. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00176 · Cited by 64
Strategies for preventing type 2 diabetes: an update for clinicians
Khavandi, K., Amer, H., Ibrahim, B., & Brownrigg, J. R. W. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313494986 · Cited by 62
Li, S., Xiao, J., Ji, L., Weng, J., Jia, W., Lu, J., Zhou, Z., Guo, X., Liu, J., Shan, Z., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.015 · Cited by 60
Xiong, X.-L., Zhang, R.-X., Bi, Y., Zhou, W., Yu, Y., & Zhu, D. (2019) · Current Medical Science · doi:10.1007/s11596-019-2077-4 · Cited by 62
Rathmann, W., Scheidt‐Nave, C., Roden, M., & Herder, C. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0331 · Cited by 59
How diabetes risk assessment tools are implemented in practice: A systematic review
Dhippayom, T., Chaiyakunapruk, N., & Krass, I. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.008 · Cited by 52
Jepson, C., Hsu, J. Y., Fischer, M. J., Kusek, J. W., Lash, J. P., Ricardo, A. C., Schelling, J. R., Feldman, H. I., Appel, L. J., Feldman, H. I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.017 · Cited by 53
Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study
Mühlenbruch, K., Ludwig, T., Jeppesen, C., Joost, H.-G., Rathmann, W., Meisinger, C., Peters, A., Boeing, H., Thorand, B., & Schulze, M. B. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.013 · Cited by 52
Heianza, Y., Arase, Y., Hsieh, S. D., Saito, K., Tsuji, H., Kodama, S., Tanaka, S., Ohashi, Y., Shimano, H., Yamada, N., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2712-0 · Cited by 53
Ruı́z-Argüelles, A., Méndez-Huerta, M. A., Lozano, C. D., & Ruiz-Argüelles, G. J. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.08.014 · Cited by 60
Risk assessment tools for detecting those with pre-diabetes: A systematic review
Barber, S. R., Davies, M. J., Khunti, K., & Gray, L. J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.007 · Cited by 50
Shieh, A., Han, W., Ishii, S., Greendale, G. A., Crandall, C. J., & Karlamangla, A. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4262 · Cited by 51
Zhang, M., Zhang, H., Wang, C., Ren, Y., Wang, B., Zhang, L., Yang, X., Zhao, Y., Han, C., Pang, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152054 · Cited by 53
Paprott, R., Mühlenbruch, K., Mensink, G., Thiele, S., Schulze, M. B., Scheidt‐Nave, C., & Heidemann, C. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000280 · Cited by 56
Self-citationPrognostic Modeling and Prevention of Diabetes Using Machine Learning Technique
Perveen, S., Shahbaz, M., Keshavjee, K., & Guergachi, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49563-6 · Cited by 51
Evans, M., Morgan, A. R., Patel, D., Dhatariya, K., Greenwood, S. A., Newland‐Jones, P., Hicks, D., Yousef, Z. R., Moore, J., Kelly, B., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00963-2 · Cited by 53
Overview of Screening: Where We Are and Where We May Be Headed
Harris, R. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr006 · Cited by 44
Heianza, Y., Arase, Y., Tsuji, H., Saito, K., Amakawa, K., Hsieh, S. D., Kodama, S., Shimano, H., Yamada, N., Hara, S., et al. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.04.016 · Cited by 42
Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics
Mastrangelo, A., & Barbas, C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47656-8_10 · Cited by 42
Genetic Risk, a Healthy Lifestyle, and Type 2 Diabetes: the Dongfeng-Tongji Cohort Study
Han, X., Wei, Y., Hu, H., Wang, J., Li, Z., Wang, F., Long, T., Yuan, J., Yao, P., Wei, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz325 · Cited by 44
Abbasi, A., Bakker, S. J. L., Corpeleijn, E., van der A, D. L., Gansevoort, R. T., Gans, R. O. B., Peelen, L. M., van der Schouw, Y. T., Stolk, R. P., Navis, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051496 · Cited by 44
Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause
Shieh, A., Ishii, S., Greendale, G. A., Cauley, J. A., Lo, J. C.-M., & Karlamangla, A. S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2889 · Cited by 42
Fletcher, E., Burns, A., Wiering, B., Lavu, D., Shephard, E., Hamilton, W., Campbell, J. L., & Abel, G. (2023) · BMC Primary Care · doi:10.1186/s12875-023-01973-2 · Cited by 40
Ge, S., Xu, X., Zhang, J., Hou, H., Wang, H., Liu, D., Zhang, X., Song, M., Li, D., Zhou, Y., et al. (2019) · The EPMA Journal · doi:10.1007/s13167-019-0159-9 · Cited by 42
Lilja, M., Rolandsson, O., Norberg, M., & Söderberg, S. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0123 · Cited by 39
Mühlenbruch, K., Jeppesen, C., Joost, H., Boeing, H., & Schulze, M. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064307 · Cited by 39
Self-citationGuasch‐Ferré, M., Bulló, M., Costa, B., Martínez‐González, M. Á., Ibarrola-Jurado, N., Estruch, R., Barrio, F., Salas‐Salvadó, J., & for the PREDI-PLAN Investigators (2012) · PLoS ONE · doi:10.1371/journal.pone.0033437 · Cited by 38
Echouffo-Tcheugui, J. B., Dieffenbach, S. D., & Kengne, A. P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.023 · Cited by 38
Dunbar, J., Hernan, A. L., Janus, E. D., Vartiainen, E. A., Laatikainen, T. K., Versace, V. L., Reynolds, J., Best, J. D., Skinner, T. C., O'Reilly, S. L., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000131 · Cited by 38
Venkatrao, M., Nagarathna, R., Patil, S. S., Singh, A., Rajesh, S. K., & Nagendra, H. R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108037 · Cited by 37
Janghorbani, M., Almasi, S. Z., & Amini, M. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0709-5 · Cited by 36
Screening for hyperglycemia in the developing world: Rationale, challenges and opportunities
Echouffo-Tcheugui, J. B., Mayige, M. T., Ogbera, A. O., Sobngwi, E., & Kengne, A. P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.003 · Cited by 35
Khunti, K., Mani, H., Achana, F. A., Cooper, N. J., Gray, L. J., & Davies, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135702 · Cited by 39
LACY, M. E., Wellenius, G. A., Carnethon, M. R., Loucks, E. B., Carson, A. P., Luo, X., Kiefe, C. I., Gjelsvik, A., Gunderson, E. P., Eaton, C. B., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0509 · Cited by 32
Mühlenbruch, K., Heraclides, A., Steyerberg, E. W., Joost, H., Boeing, H., & Schulze, M. B. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9744-0 · Cited by 34
Self-citationTime to question the NHS diabetes prevention programme
Barry, E., Roberts, S. A., Finer, S., Vijayaraghavan, S., & Greenhalgh, T. (2015) · BMJ · doi:10.1136/bmj.h4717 · Cited by 37
Xie, R., Herder, C., Sha, S., Peng, L., Brenner, H., & Schöttker, B. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102971 · Cited by 36
Lifestyle interventions in preventing new type 2 diabetes in Asian populations
Modesti, P. A., Galanti, G., Calà, P., & Calabrese, M. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1325-2 · Cited by 34
Risco para diabetes mellitus tipo 2 e fatores associados
Marinho, N. B. P., de Vasconcelos, H. C. A., Alencar, A. M. P. G., de Almeida, P. C., & Damasceno, M. M. C. (2013) · Acta Paulista de Enfermagem · doi:10.1590/s0103-21002013000600010 · Cited by 33
Arija, V., Fernández‐Cao, J. C., Basora, J., Bulló, M., Aranda, N., Estruch, R., Martínez‐González, M. Á., & Salas‐Salvadó, J. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002852 · Cited by 31
Godino, J., van Sluijs, E. M. F., Marteau, T. M., Sutton, S. R., Sharp, S. J., & Griffin, S. J. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-444 · Cited by 30
Self-citationThreshold-Free Measures for Assessing the Performance of Medical Screening Tests
Yuan, Y., Su, W., & Zhu, M. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00057 · Cited by 31
Cardiometabolic risk estimation using exposome data and machine learning
Atehortúa, A., Gkontra, P., Camacho, M., Díaz, O., Bulgheroni, M., Simonetti, V., Chadeau‐Hyam, M., Felix, J. F., Sebert, S. P., & Lekadir, K. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105209 · Cited by 32
Abdallah, M., Sharbaji, S., Sharbaji, M., Daher, Z., Faour, T., Mansour, Z., & Hneino, M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00590-8 · Cited by 34
The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease
Mehta, N. N., Dangas, K., Ditmarsch, M., Rensen, P. C. N., Dicklin, M. R., & Kastelein, J. J. P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106972 · Cited by 28
Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study
Janghorbani, M., Adineh, H., & Amini, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.018 · Cited by 30
Bernabé‐Ortiz, A., Smeeth, L. L., Gilman, R. H., Sánchez-Abanto, J., Checkley, W., Miranda, J. J., & CRONICAS Cohort Study Group (2016) · Journal of Diabetes Research · doi:10.1155/2016/8790235 · Cited by 33
Quantifying the risk of type 2 diabetes in East London using the QDScore: a cross-sectional analysis
Mathur, R., Noble, D. J., Smith, D. M., Greenhalgh, T., & Robson, J. P. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x656793 · Cited by 26
Godino, J., van Sluijs, E. M. F., Sutton, S. R., & Griffin, S. J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.004 · Cited by 25
Self-citationEvaluation of Major Online Diabetes Risk Calculators and Computerized Predictive Models
Štiglic, G., & Pajnkihar, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142827 · Cited by 26
Hu, P. L., Koh, Y. L. E., & Tan, N. C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.019 · Cited by 26
A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.
Grass, G. M., & Lee, V. H. (1993) · PubMed · Cited by 25
Risk predictive modelling for diabetes and cardiovascular disease
Kengne, A. P., Masconi, K. L., Mbanya, V. N., Lekoubou, A., Echouffo-Tcheugui, J. B., & Matsha, T. E. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.853025 · Cited by 24
A threshold‐free summary index of prediction accuracy for censored time to event data
Yan Yuan, A., Zhou, Q. M., Li, B., Cai, H., Chow, E. J., & Armstrong, G. T. (2018) · Statistics in Medicine · doi:10.1002/sim.7606 · Cited by 24
Thorand, B., Zierer, A., Büyüközkan, M., Krumsiek, J., Bauer, A., Schederecker, F., Sudduth-Klinger, J., Meisinger, C., Grallert, H., Rathmann, W., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa953 · Cited by 24
Buccheri, E., Dell'Aquila, D., & Russo, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108722 · Cited by 24
Metadata
- Authors
- Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B.
- Affiliations
- German Institute of Human Nutrition (DE)
- Corresponding author
- Schulze, M. B.
- Venue
- Epidemiologic Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-27
- Volume
- 33
- Issue
- 1
- Pages
- 46-62
- ISSN
- 0193-936X (ISSN-L)
- 1478-6729
- PMC
- PMC3132807
- OpenAlex
- W2113648435
- Cited by
- 297
- References
- 130
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 12 · 2023: 12 · 2022: 21 · 2021: 11 · 2020: 16 · 2019: 13 · 2018: 17 · 2017: 19 · 2016: 22 · 2015: 31 · 2014: 26 · 2013: 35 · 2012: 29
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Epidemiologic Reviews (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute for Health and Care Research (RP-PG-0606-1259)
- European Commission (LSHM_CT_2006_037197)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes risk score, risk prediction, impaired glucose tolerance, external validation, discriminatory ability, absolute risk estimation, fasting blood glucose, genetic profiling, diabetes prevention, risk communication
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Predictive Value of Tests, Surveys and Questionnaires, Risk Factors, Reproducibility of Results, Risk Assessment, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review